These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11206007)

  • 1. Altered nuclear localization of bax protein in BCNU-resistant glioma cells.
    Joy A; Panicker S; Shapiro JR
    J Neurooncol; 2000 Sep; 49(2):117-29. PubMed ID: 11206007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells.
    Lytle RA; Jiang Z; Zheng X; Rich KM
    J Neurooncol; 2004 Jul; 68(3):233-41. PubMed ID: 15332326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA.
    Shou J; Ali-Osman F; Multani AS; Pathak S; Fedi P; Srivenugopal KS
    Oncogene; 2002 Jan; 21(6):878-89. PubMed ID: 11840333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of Dickkopf-1 increases the sensitivity of human glioma cell line SHG44 to BCNU.
    Zhou Y; Li W; Xu Q; Huang Y
    J Exp Clin Cancer Res; 2010 Oct; 29(1):131. PubMed ID: 20920327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
    Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemosensitivity of human malignant glioma: modulation by p53 gene transfer.
    Trepel M; Groscurth P; Malipiero U; Gulbins E; Dichgans J; Weller M
    J Neurooncol; 1998 Aug; 39(1):19-32. PubMed ID: 9760067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of Gli1 by small-interfering RNA enhances the effects of BCNU on the proliferation and apoptosis of glioma U251 cells.
    Guo W; Tian H; Dong X; Bai J; Yang X
    Int J Clin Exp Pathol; 2015; 8(7):7762-73. PubMed ID: 26339341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human glioma cell proliferation by altered Bax/Bcl-2-p53 expression and apoptosis induction by Rhaponticum carthamoides extracts from transformed and normal roots.
    Skała E; Sitarek P; Toma M; Szemraj J; Radek M; Nieborowska-Skorska M; Skorski T; Wysokińska H; Śliwiński T
    J Pharm Pharmacol; 2016 Nov; 68(11):1454-1464. PubMed ID: 27696406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bax expressed from a herpes viral vector enhances the efficacy of N,N'-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma model.
    Lee A; DeJong G; Guo J; Bu X; Jia WW
    Cancer Gene Ther; 2000 Aug; 7(8):1113-9. PubMed ID: 10975671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression.
    Wang GB; Liu JH; Hu J; Xue K
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5065-5071. PubMed ID: 29228450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cellular pathways involved in glioblastoma response to the chemotherapeutic agent 1, 3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by gene expression profiling.
    Rhee CH; Ruan S; Chen S; Chenchik A; Levin VA; Yung AW; Fuller GN; Zhang W
    Oncol Rep; 1999; 6(2):393-401. PubMed ID: 10023010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.
    Del Bufalo D; Trisciuoglio D; Biroccio A; Marcocci L; Buglioni S; Candiloro A; Scarsella M; Leonetti C; Zupi G
    J Cell Biochem; 2001 Aug 21-Sep 5; 83(3):473-83. PubMed ID: 11596115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a 116 kDa protein able to bind 1,3-bis(2-chloroethyl)-1-nitrosourea-damaged DNA as poly(ADP-ribose) polymerase.
    Malapetsa A; Noë AJ; Poirier GG; Desnoyers S; Berger NA; Panasci LC
    Mutat Res; 1996 Jan; 362(1):41-50. PubMed ID: 8538647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Movement of Bax from the cytosol to mitochondria during apoptosis.
    Wolter KG; Hsu YT; Smith CL; Nechushtan A; Xi XG; Youle RJ
    J Cell Biol; 1997 Dec; 139(5):1281-92. PubMed ID: 9382873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
    Gallerne C; Prola A; Lemaire C
    Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells.
    Zheng LT; Lee S; Yin GN; Mori K; Suk K
    J Neurochem; 2009 Dec; 111(5):1238-51. PubMed ID: 19860839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.
    Pepper C; Hoy T; Bentley P
    Leuk Lymphoma; 1998 Jan; 28(3-4):355-61. PubMed ID: 9517506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.